Literature DB >> 17277774

Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.

Susheel Vijayraghavan1, Min Wang, Shari G Birnbaum, Graham V Williams, Amy F T Arnsten.   

Abstract

Dopamine (DA) D1 receptor (D1R) stimulation in prefrontal cortex (PFC) produces an 'inverted-U' dose-response, whereby either too little or too much D1R stimulation impairs spatial working memory. This response has been observed across species, including genetic linkages with human cognitive abilities, PFC activation states and DA synthesis. The cellular basis for the inverted U has long been sought, with in vitro intracellular recordings supporting a variety of potential mechanisms. The current study demonstrates that the D1R agonist inverted-U response can be observed in PFC neurons of behaving monkeys: low levels of D1R stimulation enhance spatial tuning by suppressing responses to nonpreferred directions, whereas high levels reduce delay-related firing for all directions, eroding tuning. These sculpting actions of D1R stimulation are mediated in monkeys and rats by cyclic AMP intracellular signaling. The evidence for an inverted U at the cellular level in behaving animals promises to bridge in vitro molecular analyses with human cognitive experience.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277774     DOI: 10.1038/nn1846

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  391 in total

1.  Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory.

Authors:  E Y Yuen; W Liu; I N Karatsoreos; Y Ren; J Feng; B S McEwen; Z Yan
Journal:  Mol Psychiatry       Date:  2010-05-11       Impact factor: 15.992

Review 2.  The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.

Authors:  Amy F T Arnsten
Journal:  Expert Rev Neurother       Date:  2010-10       Impact factor: 4.618

3.  Use of siRNA in knocking down of dopamine receptors, a possible therapeutic option in neuropsychiatric disorders.

Authors:  Mohammad-Reza Noori-Daloii; Majid Mojarrad; Ali Rashidi-Nezhad; Majid Kheirollahi; Ali Shahbazi; Mehdi Khaksari; Asghar Korzebor; Ali Goodarzi; Maryam Ebrahimi; Ali Reza Noori-Daloii
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

Review 4.  MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

Authors:  Andrea de Bartolomeis; Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

Review 5.  The role of neuromodulators in selective attention.

Authors:  Behrad Noudoost; Tirin Moore
Journal:  Trends Cogn Sci       Date:  2011-11-08       Impact factor: 20.229

6.  Dynamically changing effects of corticosteroids on human hippocampal and prefrontal processing.

Authors:  Marloes J A G Henckens; Zhenwei Pu; Erno J Hermans; Guido A van Wingen; Marian Joëls; Guillén Fernández
Journal:  Hum Brain Mapp       Date:  2011-09-21       Impact factor: 5.038

7.  Interactions of Motivation and Cognitive Control.

Authors:  Debbie M Yee; Todd S Braver
Journal:  Curr Opin Behav Sci       Date:  2017-11-24

8.  Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation.

Authors:  Rouba Kozak; Tamás Kiss; Keith Dlugolenski; David E Johnson; Roxanne R Gorczyca; Kyle Kuszpit; Brian D Harvey; Polina Stolyar; Stacey J Sukoff Rizzo; William E Hoffmann; Dmitri Volfson; Mihaly Hajós; Jennifer E Davoren; Amanda L Abbott; Graham V Williams; Stacy A Castner; David L Gray
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

9.  Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans.

Authors:  Alessandro Bertolino; Leonardo Fazio; Annabella Di Giorgio; Giuseppe Blasi; Raffaella Romano; Paolo Taurisano; Grazia Caforio; Lorenzo Sinibaldi; Gianluca Ursini; Teresa Popolizio; Emanuele Tirotta; Audrey Papp; Bruno Dallapiccola; Emiliana Borrelli; Wolfgang Sadee
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

10.  Dopamine D1 receptor antagonism in the prelimbic cortex blocks the reinstatement of heroin-seeking in an animal model of relapse.

Authors:  Ronald E See
Journal:  Int J Neuropsychopharmacol       Date:  2009-02-23       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.